Sanchitongtshu Plus Asprine for Minor Ischemic Stroke or Transient Ischemic Attack: A Randomized Double-blind Study

Not yet recruiting

Phase N/A Results N/A

Summary of Purpose

Agents of sanchi have been widely used as a complementary medicine for stroke in China. Sanchitongshu is a new Chinese patent medicine extracted from sanchi which has stronger anti-platelet activity than other agents of sanchi. The investigators's aim was to investigate the synergistic action of aspirin combined with sanchitongshu capsule in the treatment of patients with minor ischemic stroke and transient...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 22 November 2016.

1 Dec 2016 18 Nov 2016 1 Nov 2019 1 Nov 2019 1 Nov 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

Not available

Contacts